PTC Therapeutics Newsroom

PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireDec 23 21:00

J.P. Morgan's Top Healthcare Stocks for 2025

Seeking AlphaDec 21 00:30

Express News | PTC Therapeutics Inc: PTC's Fourth Approval Application Submitted to FDA in 2024

BreakingsDec 19 21:00

Express News | PTC Therapeutics Announces Vatiquinone Nda Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia

BreakingsDec 19 21:00

PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia

PR NewswireDec 19 21:00

Express News | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 18 05:30

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR NewswireDec 18 05:30

Morgan Stanley Upgrades PTC, Cuts Immuneering, Amicus

Seeking AlphaDec 14 03:42

PTC Therapeutics Raised to Overweight From Equal-Weight by Morgan Stanley

Dow JonesDec 14 02:02 · Ratings

PTC Therapeutics Analyst Ratings

BenzingaDec 14 01:51 · Ratings

RBC Capital Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsDec 13 20:33 · Ratings

PTC Therapeutics (PTCT) Receives a Buy From RBC Capital

TipRanksDec 13 20:08 · Ratings

Morgan Stanley Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $67

Futu NewsDec 13 18:33 · Ratings

Morgan Stanley Upgrades PTC Therapeutics(PTCT.US) to Buy Rating, Raises Target Price to $67

Futu NewsDec 13 09:32 · Ratings

Raymond James, Cantor Bullish on UniQure Following FDA Update

Seeking AlphaDec 11 02:11

Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder

BenzingaDec 7 02:10

PTC Therapeutics: Hold Rating Amid Strategic Collaboration With Novartis and Clinical Uncertainties

TipRanksDec 6 13:55 · Ratings

Citi Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $32

Futu NewsDec 6 00:35 · Ratings

PTC Therapeutics(PTCT.US) Officer Sells US$5.02 Million in Common Stock

$PTC Therapeutics(PTCT.US)$ Officer Boulding Mark Elliott sold 95,908 shares of common stock on Dec 2, 3, 2024 at an average price of $52.37 for a total value of $5.02 million.Source: Announcement

Futu NewsDec 5 06:23

PTC Therapeutics(PTCT.US) Officer Sells US$3.73 Million in Common Stock

$PTC Therapeutics(PTCT.US)$ Officer Almstead Neil Gregory sold 71,610 shares of common stock on Dec 2, 2024 at an average price of $52.06 for a total value of $3.73 million.Source: Announcement What

Futu NewsDec 5 06:23